Drugmaker Merck divests investment in Moderna

(Reuters) – U.S. drugmaker Merck & Co said on Wednesday it had sold its equity investment in vaccine developer Moderna Inc.

Merck said it had achieved a substantial gain on its direct holding in Moderna, particularly this year, as the company moved closer to developing a coronavirus vaccine.

Reporting by Manas Mishra in Bengaluru; Editing by Anil D’Silva